224.93 5.76 (2.63%)

30.48% Fall from 52W High

104.6K NSE+BSE Volume

NSE 19 Mar, 2025 1:39 PM (IST)



Board Meetings - Wanbury Ltd.

The latest board meeting for Wanbury Ltd. took place on 12 Feb 2025, for the purpose of Quarterly Results & Others

Ex-date Purpose Notes
12 Feb 2025 Quarterly Results & Others Inter-alia, to consider 1. The issue of senior, secured, unlisted redeemable and non- convertible debentures on private placement basis and other matters in relation to such issue.
13 Nov 2024 Quarterly Results -
12 Aug 2024 Quarterly Results -
16 May 2024 Audited Results -
24 Jan 2024 Quarterly Results -
20 Oct 2023 Quarterly Results & Preferential issue Inter-alia, to consider and evaluate proposals for raising of funds by way of a preferential issue/allotment and private placement to promoters/promoter group of the Company.
11 Aug 2023 Quarterly Results -
09 Jun 2023 Audited Results (Revised)
14 Feb 2023 Quarterly Results -
28 Nov 2022 Quarterly Results (Revised)
10 Aug 2022 Quarterly Results -
22 Jun 2022 Audited Results -
17 Feb 2022 Preferential issue of shares -
08 Feb 2022 Quarterly Results -
25 Nov 2021 Quarterly Results (Revised)
20 Oct 2021 Quarterly Results -
20 Sep 2021 Quarterly Results (Revised)
12 Aug 2021 Audited Results -
28 Jun 2021 Audited & Quarterly Results -
12 Feb 2021 Quarterly Results -
12 Nov 2020 Quarterly Results -
11 Sep 2020 Quarterly Results -
22 Jul 2020 Audited & Quarterly Results (Revised)
25 Jun 2020 Audited Results -
14 Feb 2020 Quarterly Results -
13 Nov 2019 Quarterly Results -
22 Oct 2019 Preferential Issue of shares inter alia, 1. The issue and allotment upto 13,95,500 Equity Shares to M/s. Edelweiss Asset Reconstruction Company Ltd. ('EARC') as a trustee of EARC Trust SC 145 on preferential basis.
20 Sep 2019 Others inter alia, to consider and approve debt settlement plan, opportunity to raise fund for settlement of debt with Lenders and review of operations.
14 Aug 2019 Quarterly Results -
30 May 2019 Audited Results -
14 Feb 2019 Quarterly Results -
14 Nov 2018 Quarterly Results -
10 Aug 2018 Quarterly Results -
09 Aug 2018 Audited Results -
08 Feb 2018 Quarterly Results -
07 Dec 2017 Quarterly Results -
11 Sep 2017 Quarterly Results -
30 May 2017 Audited Results -
14 Feb 2017 Quarterly Results -
29 Nov 2016 Quarterly Results (Revised from 08/11/2016)
12 Aug 2016 Quarterly Results -
18 May 2016 Audited Results -
11 Feb 2016 Quarterly Results -
05 Nov 2015 Quarterly Results 1. Grant of Employee Stock Option Plan (ESOP) to the extent of 3,00,000 equity shares to the employee/s of the Company. 2. Assignment of Financial Assistance granted to Wanbury Limited by State Bank.
28 Sep 2015 Others 1. Resignation of Mr. A. L. Bongirwar as Independent Director of the Company vides his dated September 28, 2015. 2. Resignation of Dr. P. L. Tiwari as Independent Director of the Company.
13 Aug 2015 Quarterly Results Appointment of Ms. Anita Belani as an Additional Independent Woman Director.
21 May 2015 Audited Results Mr. Jitendra J. Gandhi as Compliance Officer of the Company who has joined as Company Secretary of the Company w.e.f. April 20, 2015.
11 Feb 2015 Quarterly Results -
26 Nov 2014 Quarterly Results -
07 Aug 2014 Quarterly Results -
12 May 2014 Quarterly Results -
11 Feb 2014 Quarterly Results -
14 Nov 2013 Quarterly Results -
12 Aug 2013 Quarterly Results -
30 May 2013 Audited Results -
07 Feb 2013 Quarterly Results -
05 Nov 2012 Quarterly Results -
06 Aug 2012 Quarterly Results -
28 May 2012 Audited Results -
10 Feb 2012 Quarterly Results -
07 Nov 2011 Quarterly Results -
27 Sep 2011 Others -
30 May 2011 Audited Results -
02 Feb 2011 Quarterly Results -
29 Oct 2010 Quarterly Results -
12 Aug 2010 Quarterly Results -
28 May 2010 Audited Results -
22 Jan 2010 Quarterly Results -
23 Dec 2009 Employees Stock Option Plan & Others To consider the Employee Stock Option Scheme for the Employees of the Company & to draft the rehabilitation scheme for the Merger of Pharmaceuticals Products of India Ltd. with the Company.
28 Oct 2009 Quarterly Results -
29 Sep 2009 To consider the Cost Audit Report inter alia, to consider the Cost Audit Report of the Company for the financial year 2008-2009 i.e., for the 6 months period from October 01, 2008 to March 31, 2009.
27 Jul 2009 Quarterly Results -
30 Jun 2009 Audited Results 6 months period from 1st October 2008 to 31st March 2009.
03 Jun 2009 Others To avail the Term Loan of Rs 19.5 Crore, working capital facility of Rs 11 Crore & Availing Fund Based Working Capital Facility of Rs 9.50 Cr. & Non fund Based Working Capital Facility of Rs 7.90 Cr.
30 Jan 2009 Quarterly Results -
31 Dec 2008 Audited Results, Dividend & Others inter alia, to consider the date and notice of Annual General Meeting. (For 18 months)
28 Nov 2008 To appoint Cost Auditor inter alia, to consider appointment of Cost Auditor of the company for the financial year 2008-2009.
29 Jul 2008 Quarterly Results -
27 Jun 2008 Quarterly Results -
28 Apr 2008 Appointment of Cost Auditor -
30 Jan 2008 Quarterly Results -
31 Oct 2007 Quarterly Results -
27 Sep 2007 Others inter alia, to consider the following: 1. The Cost Audit Report for the financial year 2006-2007. 2. The sitting fees to be paid to the non-executive directors for attending the Board Meeting.
30 Jul 2007 Quarterly Results -
29 Jun 2007 Audited Results & Dividend -
28 May 2007 Appointment of Cost Auditor To consider and approve the appointment of Cost Auditor for the Financial Year 2007-2008.
14 Mar 2007 To consider & allot FCCB's To consider and approve allotment of Foreign Currency Convertible Bonds (FCCBs).
31 Jan 2007 Quarterly Results -
04 Jan 2007 Enhancement of Working Capital Limits 1. Enhancement of Working Capital Limits sanctioned by Consortium of Bank of India, Exim Bank and Dhanlakshmi Bank. 2. Foreign Currency Convertible Bonds (FCCB) / Qualified Institutional Placement.
16 Oct 2006 Quarterly Results -
07 Sep 2006 Others To convene Extra Ordinary General Meeting to get the approval of the Shareholders of the Company for the scheme of merger of Doctors Organic Chemicals Ltd with the Company.
31 Jul 2006 Quarterly Results -
26 Jun 2006 Accounts, Final Dividend & Merger -
28 Apr 2006 Others Appointment of Cost Auditor - Mr Hemant V Shah for the financial year 2006-2007 subject to the approval of Central Government.
30 Jan 2006 Quarterly Results & Interim Dividend 1) To consider and approve working capital facilities and short term Foreign Exchange facility from DBS Bank of Rs. 7.50 crores. 2) To consider and approve credit limit from State Bank of India.
28 Oct 2005 Half Yearly Results -
03 Oct 2005 Allotment of equity shares To consider & approve the allotment of equity shares for issue of GDRs.
12 Sep 2005 Amalgamation Merger of The Pharmaceuticals Products of India Ltd. with the Company
30 Jul 2005 Quarterly Results -
24 Jun 2005 Increase in Authorised Capital -